Key Publications
OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs
Yang N, Wang Y, Liu S, Tariq SB, Luna JM, Mazo G, Tan A, Zhang T, Wang J, Yan W, Choi J, Rossi A, Xiang JZ, Rice CM, Merghoub T, Wolchok JD, Deng L.
Journal of Experimental Medicine. 2023;220(8):e20221166. doi: 10.1084/jem.20221166.
PubMed | Journal
Investigation of dynamic solution interactions between NET-1 and UNC-5B by multi-wavelength analytical ultracentrifugation
Gabir H, Gupta M, Meier M, Heide F, Koch M, Stetefeld J, Demeler B.
European Biophysics Journal. 2023;52(4–5):473–481. doi: 10.1007/s00249-023-01644-1.
PubMed | Journal
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Pelin A, Wang J, Bell J, Le Boeuf F.
Oncolytic Virotherapy. 2018;7:25–35. doi: 10.2147/OV.S137159.
PubMed | Journal
Subscribe to our emails
Stay up to date on Genvira Biosciences